Reply to thread

This is the exact problem.  A typical post from a typical Amgen Manager.  The reason the bone health hell hole is failing is micro managerment, horrible business model (Amgen is the only company where a territory in New York City should produce the exact same as a territory in Maine, yeah OKAY), constant strategy shifing, and mark my words this drug won't be successful in primary care until Amgen gets a self injectable label and patients can use Part D consistently.  It's no surprise CT can't figure this out. Wall street demand his exit!!!!!!!!!